Oh to be listed in Australia.
With solid pipeline (by Australian biotech standards), availability of R&D grants, good cash position along with assets like Inavir and Relenza, we'd shoot the lights out.
Oh to be listed in Australia. With solid pipeline (by Australian...
Add to My Watchlist
What is My Watchlist?